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Abstract 
Epidemiological evidence has linked non-nutritive sweeteners (NNS) with potential adverse 
health outcomes such as obesity, metabolic dysfunction, and poor blood glucose control. 
This study aims to ascertain the acute glycaemic effects of the NNS aspartame and 
acesulfame-K in diet cola when consumed prior to a glucose load. Ten participants were 
recruited to take part and instructed to attend the laboratory in a fasted state on two 
occasions. Participants drank a preload containing either 250 mL carbonated water (CW) or 
250 mL caffeine-free diet cola (DC) 10 minutes prior to consumption of a 25 g glucose 
beverage in 125 mL water. Using portable glucometers, blood glucose was measured both 
before and 10 minutes after preload consumption, and every 15 minutes thereafter for a 120-
minute period. A paired t test showed no significant difference in incremental area under the 
curve (AUC) for blood glucose between preload conditions (117.8 ± 16.1 versus 115.1 ± 
13.4 mmol·L-1·120 min-1 for CW and DC respectively, P>0.05). Similarly, the decremental 
AUC was not significantly different between conditions (-22.1 ± 5.3 compared with -40.7 ± 
9.9 mmol·L-1·120 min-1 for CW and DC respectively, P>0.05). Blood glucose increments 
were significantly lower in the DC compared with the CW preload condition at 120 minutes 
only. Incremental blood glucose values were not significantly different between conditions at 
any other time point. Findings demonstrate the glycaemic inactivity of the NNS aspartame 
and acesulfame-K in UK diet cola, though the discrepancy between conditions at 120 
minutes warrants further investigation. 
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Introduction 
Overweight and obesity are widespread, having doubled worldwide since 1980 
(Withrow and Alter, 2011). Prevalence is continuing to increase both considerably 
and consistently. Figures from the most recent Health Survey for England show that 
64% of UK adults aged 16 and over are overweight or obese, a rise of 2.5% from the 
previous year (Office for National Statistics, 2018). Obesity and consequent 
comorbidities place an ever-increasing burden on state healthcare systems. For 
example, the annual cost to the UK National Health Service of type 2 diabetes 
mellitus (T2DM) alone was estimated at over £21 billion in 2010/2011 and this 
number is expected to rise by at least 50% by 2035 (Hex et al., 2012). 
 
The popularity of sugar-sweetened beverages (SSBs) in the Western diet has been 
previously linked to obesity and T2DM (Greenwood et al., 2014; van Baak and 
Astrup, 2009). Hence, both the World Health Organisation (WHO; 2015) and the UK 
Scientific Advisory Committee on Nutrition (2015) recommend that free sugars, 
defined as the monosaccharides and disaccharides added to food and drink as well 
as naturally occurring sugars in fruit juices (WHO, 2015), comprise no more than 5% 
of daily energy intake. Therefore, replacement of SSBs with low-energy, artificially-
sweetened alternatives may aid individuals in reducing overall energy intake leading 
to potential weight loss (Miller and Perez, 2014), in addition to improving other 
aspects of wellbeing such as dental health (Fitch et al., 2012). 
 
Non-nutritive sweeteners (NNS) are zero- to low-energy sugar substitutes often 
orders of magnitude sweeter than sucrose that may permit reduced sugar and 
energy intake while simultaneously preserving the palatability of foods and drinks 
(Burke and Small, 2015). According to the British Dietetic Association (2017), there 
are currently eleven types of artificial sweeteners licensed for use in the UK, 
including sucralose, aspartame, saccharin and acesulfame-K. Consumables 
containing NNS are not limited to beverages only; NNS may be found in common 
food products such as cereals and sugar-free condiments in addition to household 
items such as toothpaste and dental floss (Sylvetsky and Rother, 2016). Although 
the ubiquity of NNS makes it difficult to ascertain consumption at a population level, 
an estimated 2.3 million UK adults (aged ≥ 15 years) consumed artificial sweeteners 
at least four times per day in 2017 (Statista, 2018). It is therefore of paramount 
importance to determine the potential benefits or deleterious effects associated with 
NNS consumption. 
 
Positive effects of NNS include the potential for decreased daily energy intake and 
improved glycaemic control as reported by Raben and Richelsen (2012) in a recent 
review of the scientific literature. However, the research in this area is equivocal at 
present regarding the physiological and metabolic consequences of NNS, with many 
studies unable to present clear evidence of either positive or negative effects (Mattes 
and Popkin, 2009; Wiebe et al., 2011). However, some recent evidence points 
towards deleterious effects of NNS consumption such as the disruption of glucose 
metabolism and glycaemic homeostasis (Swithers, 2013). 
 
Consumption of NNS has been consistently linked epidemiologically with an 
increased likelihood of overweight and obesity, metabolic syndrome, and type 2 
diabetes mellitus (Azad et al., 2017; Imamura et al., 2015). Evaluating the 
robustness of these observational associations is difficult. The additional risk of 
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obesity and other adverse metabolic outcomes with increased NNS consumption 
may be owing to reverse causality (Mattes and Popkin, 2009). That is, individuals 
with higher pre-existing BMI wishing to reduce adiposity may choose to increase 
intakes of NNS in order to lessen sugar and energy intakes. Prospective studies 
show that individuals consuming large quantities of NNS frequently have a higher 
body mass index at baseline than those who do not consume NNS (de Koning et al., 
2011). However, the positive relationship between NNS and risk of obesity and 
metabolic dysfunction persists even in studies adjusting for baseline BMI 
(Bhupathiraju et al., 2013; Fowler et al., 2008). 
 
The physiological mechanisms that underlie the association between consumption of 
NNS and metabolic dysfunction are poorly understood (Pereira, 2014). The 
digestion, metabolism and assimilation of ingested nutrients are optimised through 
gastrointestinal changes resulting from cephalic phase (e.g. gustatory/olfactory) 
signals (Smeets et al., 2010). Insulin levels, for example, may be raised after 
gustatory exposure to foods (Zhu et al., 2014). This cephalic phase insulin response 
is strongest after oral exposure to carbohydrates (Dušková et al., 2013), and may be 
necessary to predict energy intake and optimise digestion and metabolism for the 
maintenance of glucose homeostasis (Ahrén and Holst, 2001). Through a Pavlovian 
lens, chronic consumption of sweet-tasting yet zero-energy foods (i.e. NNS) may 
disrupt these cephalic phase responses, lessening the association of sweet taste 
with energy intake and resulting in the potential dysregulation of metabolism and 
glycaemic homeostasis (Swithers, 2013; Yang, 2010). 
 
Some experimental trials have noted no additional glycaemic impact of NNS when 
consumed simultaneously with glucose (Little et al., 2009; Ma et al., 2010). A recent 
systematic review and meta-analysis concluded that consumption of NNS was not 
associated with significant glycaemic effects (Nichol et al., 2018). Acesulfame-K, an 
NNS used with aspartame in UK diet cola, was not included in the review’s analysis. 
A study by Bryant et al. (2014) has shown that, when co-ingested with a glucose 
load, acesulfame-K elevated the glycaemic excursion following a glucose load 
further than glucose consumption alone. However, investigating the impact of 
acesulfame-K and aspartame together in diet cola when co-ingested with glucose, 
Solomi et al. (2019) observed no significant effects on glycaemia. 
 
Experimental evidence has highlighted that NNS may exert an acute effect on the 
glycaemic response to a glucose load when consumed pre-prandially, albeit 
inconsistently (Tucker and Tan, 2017). For example, Temizkan et al. (2015) 
observed that the glycaemic area under the curve (AUC) following glucose 
consumption was significantly lower in those consuming aspartame compared with a 
water control as a preload. Aspartame added to test meals with matched 
energy/macronutrient content has also been shown to elevate the insulin response 
(Prat-Larquemin et al., 2000), although literature is conflicting in this area, with other 
studies noting no effects (Teff et al., 1995). With regards to acesulfame-K, Sylvetsky 
et al. (2016) observed a 25% increase in insulin AUC following acesulfame-K 
consumption prior to an oral glucose tolerance test, although this did not reach 
statistical significance. In contrast, Brown et al. (2012) noted no glycaemic effects of 
a preload containing sucralose and acesulfame-K. However, the AUC for glucagon-
like protein-1 (GLP-1) was 34% higher in the NNS versus the control condition. 
Similar increases in GLP-1 are reported in Sylvetsky et al. (2016), indicating that 
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NNS are not necessarily invariably metabolically inert as previously thought and may 
indeed exert an effect on metabolism. 
 
Worldwide, the market for low-energy sweeteners is expanding. Global annual 
growth for NNS from 2008-2015 has been estimated at upwards of 5% per year and 
is expected to reach a total of $2.2 billion (£1.7 billion) by 2020 (Sylvetsky and 
Rother, 2016). With the recent introduction of the 2018 Soft Drinks Industry Levy 
(Her Majesty’s Revenue & Customs, 2016) and the resulting greater cost of SSBs to 
UK consumers, nationwide purchasing and consumption of artificially-sweetened 
beverages may be likely to increase. While many studies have administered doses 
of NNS at levels that exceed reasonable or typical consumption (e.g. Hall et al., 
2003; Tey et al., 2017), this study aims to determine the acute glycaemic impact of 
NNS at commercially available levels when consumed prior to a glucose load. 
Having reviewed the literature, no study to date has focused on the glycaemic effects 
of aspartame and acesulfame-K in UK diet cola when ingested pre-prandially. 
Hence, this specific combination and its effect on glycaemia when consumed prior to 
a glucose load is a unique and novel area of research. 
Methodology 
 
Sample 
A total of ten students volunteered to participate (50% female, mean age 26.9 ± 3.3 
years, mean BMI 24.7 ± 1.1 kg·m-2). Sample size was based on methodology in past 
primary research and in a seminal review in this area (Brouns et al., 2005). A priori 
analysis revealed that ten participants was sufficient to detect a large (0.8) effect size 
with 95% power at a two-tailed significance level of 5%. Criteria for participation in 
the study included an age ≥ 18 years and a body mass index of 18 to 30 kg·m-2. 
Criteria for exclusion were known pregnancy, diabetes diagnosis, and use of 
glucocorticoids, thyroid medication, gastrointestinal motility enhancers or any other 
form of medication known to interfere with intestinal absorption. 
 
All study procedures were approved by the Research Ethics & Integrity Committee of 
the University of Plymouth Faculty of Science and Engineering. Participants 
completed a short health screening questionnaire and provided written informed 
consent prior to the start of the test protocol. 
 
Study design 
A cross-over design was selected on the basis of proposed objectives. Each 
participant underwent both treatments, thereby acting as his/her own control and 
controlling for inter-participant variations in metabolism. Individuals attended the 
laboratory on two separate mornings at 09:00 having been instructed to fast from 
22:00 the previous evening and abstain from strenuous physical activity in the 24 
hours preceding the test. Individuals consumed a 25 g glucose beverage 
(Bulkpowders, Colchester, UK) dissolved in 125 mL water on both test days. Ten 
minutes prior to glucose beverage consumption, participants consumed one of two 
preloads: either 250 mL diet cola sweetened with aspartame and acesulfame-K 
(Caffeine-Free Diet Coke, Atlanta, Georgia, USA) or a 250 mL unsweetened 
carbonated water control (Sainsbury’s Supermarkets Limited, London, UK). Precise 
quantities of the NNS aspartame and acesulfame in UK diet cola are currently 
unknown as the information is of a proprietary nature and not currently made 
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available by the manufacturer. Portable glucometers (Accu-Chek Aviva, Roche, 
Welwyn Garden City, UK) were used to measure blood glucose from fingertip 
capillaries immediately before preload consumption and again prior to consumption 
of the 25 g glucose beverage. Blood glucose was then measured thereafter in 15-
minute intervals over a 120-minute period. 
 
Data analysis 
The incremental area under the blood glucose curve (AUC) over the test period 
following a glucose load and both the carbonated water and diet cola preloads was 
ascertained using the trapezoid method as described in Brouns et al. (2005). As it 
was hypothesised that the NNS in diet cola would elevate insulin levels 
(subsequently depressing the glycaemic curve), the decremental AUC for blood 
glucose following consumption of the glucose beverage after each preload was 
calculated using similar methods as abovementioned. Descriptive statistical tests 
were performed to test for significant differences in blood glucose increments 
between the two preloads at each time point; paired t tests or Wilcoxon matched 
pairs signed rank tests were used as appropriate. Statistical analyses were 
performed using Minitab Express (Version 1.5.1) or SPSS (Version 24) for non-
parametric data sets. Data are reported as mean ± SE or median ± semi-interquartile 
range ([75th percentile minus 25th percentile]/2) for non-parametric data sets. 
 
Results 
Baseline blood glucose values from both carbonated water (CW) and diet cola (DC) 
preload conditions are displayed in Table 1. A paired t test revealed that baseline 
blood glucose measurements were significantly different across the two conditions at 
the -10 minute point (i.e. prior to preload consumption; 5.2 ± 0.1 versus 6.0 ± 0.2 
mmol·L-1 for CW and DC respectively, P<0.05). A Wilcoxon matched pairs signed 
rank test detected a difference approaching statistical significance in blood glucose 
values at the 0-minute time point (i.e. following preload consumption but prior to 
glucose beverage ingestion; 5.1 ± 0.1 compared with 6.1 ± 0.2 mmol·L-1 for CW and 
DC respectively, P=0.053). 
 
*denotes statistically significant difference. 
 
Glycaemic excursions following a 25 g glucose beverage after each preload 
are depicted in Figure 1. No significant difference in the incremental area under the 
curve for blood glucose was detected in response to the glucose load after 
carbonated water and diet cola consumption (AUC 117.8 ± 16.1 versus 115.1 ± 13.4 
mmol·L-1·120 min-1 for CW and DC respectively, P>0.05). Glucose consumption 
Table 1: Baseline blood glucose values in each test condition. 
 
Time 
point 
(min) 
Preload 
(blood glucose, mmol·L-1) 
 
P-value 
Carbonated water 
(control) 
Diet cola (sweetened 
with NNS) 
-10 5.2 ± 0.1 6.0 ± 0.2 0.020* 
0 5.1 ± 0.1 6.1 ± 0.6 0.053 
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following both preloads elicited near-superimposable excursions above pre-prandial 
levels for the first 60 minutes, each peaking at the 30-minute point. Glycaemia fell to 
below baseline after 75 minutes in both conditions, persisting for the remainder of 
the test period. 
 
 
Figure 1. Comparison of incremental blood glucose values after ingestion of a glucose 
beverage preceded by (1) carbonated water or (2) caffeine-free diet cola, sweetened with 
aspartame and acesulfame-K. Values shown are mean increments and error bars denote 
SEM. 
 
The diet cola preload elicited a non-significant greater decline below baseline when 
determined via the decremental AUC (-22.1 ± 5.3 compared with -40.7 ± 9.9 mmol·L-
1·120 min-1 for CW and DC respectively, P>0.05). Incremental blood glucose values 
were significantly lower in the diet cola compared with the carbonated water preload 
condition at 120 minutes only (-0.8 ± 0.2 compared with -0.2 ± 0.1 mmol·L-1, P<0.05; 
Table 2). Blood glucose increments were not significantly different between 
conditions at any other time point (all P>0.05; Table 2). 
Discussion 
Results showed that there were no significant differences in the incremental area 
under the blood glucose curve between preloads. Similar results have been 
observed in the literature previously. Temizkan et al. (2015) noted comparable 
glycaemic AUCs following consumption of an aspartame compared with carbonated 
water preload prior to a 75 g oral glucose tolerance test (OGTT) in healthy males 
and females. Pre-treatment with acesulfame-K has also been shown to elicit no 
additional glycaemic or insulin response (Wu et al., 2013). Similarly, Brown et al. 
(2012) noted no effects of a preload containing sucralose and acesulfame-K 
(compared with a carbonated water control) on the glycaemic response to a 75 g 
OGTT. 
 
Findings are conflicting in this area, however. Pepino et al. (2013) administered an 
NNS pre-treatment to metabolically healthy adults with obesity. The NNS preload 
condition was associated with a statistically significant 20% increase in insulin AUC 
following a glucose load compared to a water control, indicating that the NNS were 
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Data are presented as mean ± SE (time points 15 to 90 minutes) or median ± semi-interquartile 
range (time points 105 and 120 minutes).  
Paired t tests were employed to test for significant differences between groups where normally 
distributed (time points 15 to 90 minutes). Wilcoxon matched pairs signed rank tests were 
used for time points with skewed datasets (time points 105 and 120 minutes). 
*denotes statistically significant difference. 
 
impacting on insulin secretion. Sucralose was the NNS used in Pepino et al. (2013) 
and participants were individuals with obesity. Results are thus not directly 
comparable. In a more recent trial by Sylvetsky et al. (2016), healthy participants 
were administered various beverages with varying types and quantities of NNS prior 
to a 75 g OGTT. Pre-treatments sweetened with both aspartame and acesulfame-K 
(as in the present study) were associated with a 22-25% rise in insulin AUC 
compared with controls, although this did not reach statistical significance. 
 
The cephalic phase insulin response (Ahrén and Holst, 2001) is a potential 
mechanism that may underpin the (non-significant) lower blood glucose trajectory 
after 75 minutes in the diet cola condition in the present study. As alluded to earlier, 
NNS-containing foods and drinks may signal a preliminary insulin release. This may 
be as a result of NNS action on pancreatic β-cell sweet taste receptors, 
consequently inducing insulin secretion directly (Sylvetsky et al., 2016), a hypothesis 
supported by in vitro research (Nakagawa et al., 2009). Alternatively, NNS may bind 
to enteroendocrine L-cells in the gastrointestinal tract (Li et al., 2002), initiating a 
signal cascade that culminates in the release of the incretin hormone GLP-1 (Brown 
et al., 2012). Higher plasma insulin levels facilitate the assimilation of blood glucose 
into peripheral tissues via insulin-dependent glucose transporter channels (GLUT4; 
Huang and Czech, 2007), potentially depressing the incremental blood glucose 
curve following the diet cola pre-treatment as seen in Figure 1. Owing to the role of 
Table 2: Incremental blood glucose values over the test period. 
 
Time 
point 
(min) 
Preload 
(∆ blood glucose, mmol·L-1) 
 
P-value 
Carbonated water Diet cola 
15 1.8 ± 0.3 2.1 ± 0.4 0.254 
30 2.8 ± 0.4 2.7 ± 0.2 0.718 
45 1.9 ± 0.4 1.7 ± 0.4 0.649 
60 0.7 ± 0.4 0.5 ± 0.5 0.559 
75 -0.1 ± 0.2 -0.2 ± 0.3 0.703 
90 -0.3 ± 0.2 -0.6 ± 0.2 0.272 
105 -0.4 ± 0.3 -0.4 ± 0.2 0.192 
120 -0.2 ± 0.1 -0.6 ± 0.2 0.024* 
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insulin as an anabolic hormone, marginally higher insulin levels sustained for long 
periods of time (i.e. for regular consumers of NNS) may potentially result in eventual 
weight gain. However, the quantification of insulin levels was beyond the scope of 
this study and remains a key avenue for future research.  
 
The decremental area under the blood glucose curve (that is, the degree to which 
blood glucose excursions fell below baseline) was not significantly different between 
conditions, although incremental blood glucose values were significantly different at 
the 120-minute point only. Blood glucose trajectories began to diverge towards the 
end of the test, and it is possible that further divergence may have occurred at later 
stages beyond the end of the test. Therefore, an extension of the test period to 180 
minutes might allow for elucidation of differences in glycaemic response. Additional 
possibilities for future research include quantifying satiety levels throughout and 
particularly at the end of the test period (e.g. via an ad libitum food task) to ascertain 
whether NNS consumption as a preload shortens or weakens feelings of satiety. 
 
The finding that blood glucose was significantly lower (-0.6 ± 0.2 compared with -0.2 
± 0.1 mmol·L-1) in the diet cola preload condition at 120 minutes warrants further 
investigation, as it indicates that NNS consumption impacted on the glycaemic 
response to a glucose load. Pepino et al. (2013) noted similar findings in that 
glycaemia following NNS pre-treatment was significantly lower at 180 minutes, 
although this was following a 75 g OGTT. However, raw fasted blood glucose values 
at baseline (-10 minutes) were significantly (15%) higher in the diet cola group 
compared with the carbonated water preload condition in the present study. 
Similarly, values at the 0-minute point were 20% higher in the diet cola pre-treatment 
condition and showed a trend towards statistical significance. Higher baseline 
glycaemia may provide greater room for depression of blood glucose levels 
throughout the test. Since statistical tests attempting to ascertain differences in blood 
glucose at each of the time points were conducted on blood glucose increments, it is 
possible that the higher blood glucose values in the diet cola condition at baseline 
may have negatively impacted on the ability of the study to detect differences in 
response to NNS consumption. Indeed, when comparing raw blood glucose values 
at 120 minutes with a Wilcoxon matched pairs signed rank test, this difference was 
no longer significant (P=0.401; data not shown). It is therefore recommended that 
findings are treated with caution, and further investigation is required. 
 
Results add to the current body of literature demonstrating the absence of acute 
effects of NNS on glycaemia when consumed prior to a glucose beverage (e.g. 
Brown et al., 2012; Temizkan et al., 2015; Wu et al., 2013). Findings have potential 
implications for individuals with obesity electing to lessen sugar or energy intake. 
However, there is evidence to suggest that the replacement of SSBs with artificially-
sweetened beverages may elicit a compensatory effect (Mattes and Popkin, 2009), 
resulting in a proportion of the energy intake avoided through substitution with NNS 
being consumed at a later point. Regarding aspartame, this compensatory effect is 
reduced when beverages (compared with solid foods) are substituted and seldom 
reaches 100% (de la Hunty et al., 2006). Therefore, the substitution of SSBs and 
replacement with those sweetened with NNS may be an effective means of reducing 
energy intake and achieving weight loss for those with obesity. 
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However, research by Brown et al. (2012) and Temizkan et al. (2015) indicates that 
the hormonal response to NNS and a glucose load may vary depending on 
metabolic health and may differ for those with type 2 diabetes. As the present study 
was conducted in healthy participants without a T2DM diagnosis, findings cannot 
necessarily be generalised to this population. In addition, differences in type and 
quantity of NNS used in studies can make comparisons difficult. Acesulfame-K has 
been shown to activate bitter-taste receptors (Kuhn et al., 2004) whereas aspartame 
and sucralose do not (Dotson et al., 2008). Aspartame is also metabolised differently 
to sucralose. Whereas sucralose is non-metabolisable (Grotz and Munro, 2009), 
aspartame undergoes proteolysis in the gastrointestinal tract into its constituent 
parts: phenylalanine, aspartic acid and methanol (Rycerz and Jaworska-Adamu, 
2013). The effects of these metabolites on glycaemic response in the present study 
cannot be ruled out. 
 
Although the absence of acute glycaemic effects of NNS administered as a preload 
in the present study is promising, longer-term adverse consequences cannot be 
overlooked. A recent scoping review of 372 studies focusing on health outcomes 
resulting from NNS consumption noted that the evidence base is inconsistent and 
inconclusive in this area (Lohner et al., 2017). However, a review of randomised 
controlled trials and prospective cohort studies by Azad et al. (2017) concluded that 
although chronic intakes of NNS were not associated with changes in glycaemia, 
long-term NNS consumption predicted higher BMI and adverse cardiometabolic 
outcomes. In a comprehensive review of the scientific literature, Sylvetsky and 
Rother (2018) report a positive association between NNS consumption and poor 
metabolic health. Yet, sugar consumption is itself predictive of adverse long-term 
health outcomes including metabolic syndrome, T2DM (Malik et al., 2010), 
cardiovascular disease (Yang et al., 2014) and all-cause mortality (Tasevska et al., 
2014). The replacement of SSBs with those containing NNS may therefore still be 
associated with health benefit, particularly in ameliorating the risk of adverse 
outcomes. However, the long-term effects of NNS are currently poorly understood, 
and further research including prospective cohort studies and robust randomised 
controlled trials in this area is required. 
 
A number of limitations exist in the present study. All participants consumed the diet 
cola pre-treatment first. It is possible that the higher fasting blood glucose in the diet 
cola condition was as a result of the novelty of the test and/or anxiety regarding an 
initial fingertip pinprick. Anxiety is associated with elevated catecholamines (Paine et 
al., 2015) some of which facilitate hepatic glycogenolysis (Sherwin and Saccà, 1984) 
and subsequent release of glucose into the blood. It is acknowledged that this may 
have contributed to the discrepancy in baseline blood glucose values. Therefore, 
recommendations are that future research employ a more robust study design, 
requiring half of participants to consume a different pre-treatment in the first 
condition (e.g. as in Brown et al., 2012). It is possible that this may minimise 
differences in fasting blood glucose between conditions. 
 
Furthermore, participants were not given a standardised meal on the evening prior to 
the test. Evidence suggests that evening meal macronutrient composition 
(Robertson et al., 2002) and glycaemic index (Wolever et al., 1988) may affect 
glycaemic and hormonal responses the following morning. Although every effort was 
made to ensure adherence to test instructions (such as remaining fasted and 
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abstaining from strenuous activity in the 24 hours preceding the test), minor 
deviations from protocol (which may include chewing gum in the morning, for 
example) cannot be ruled out. In addition, many household items including 
toothpaste and dental floss may contain NNS and it is not possible to rule out the 
acute effects of these on study findings. Additionally, regular NNS consumption has 
been shown to affect sweet taste perception (Appleton and Blundell, 2007). The 
habitual NNS use by participants in the present study may have therefore affected 
the acute glycaemic response to an NNS pre-treatment. While future research could 
employ a screening questionnaire to include only those with or without a history of 
habitual NNS consumption, the ubiquity of NNS (Sylvetsky and Rother, 2016) would 
render this impracticable. 
 
The use of only one specific brand of diet beverage may negatively impact on the 
external validity and practical application of results. Future work may therefore 
include a number of common/popular diet beverages sweetened with NNS (e.g. 
lemonade, citrus soda, or diet energy drinks). Additionally, the possible effect of 
other ingredients (e.g. flavourings) in the diet cola or minerals in carbonated water 
cannot be disregarded. The specific quantities of the NNS aspartame and 
acesulfame-K used to sweeten UK diet cola may also impact on the external validity 
of findings, particularly in other parts of the world where the specific types and 
quantities of NNS used to sweeten diet beverages may be different. However, this 
study has a number of strengths. Firstly, the unique combination of NNS in the 
quantities present in diet cola and their effect on glycaemia represents an 
unexplored area of research. Having reviewed the literature, this study is the first to 
examine the acute glycaemic effects of the NNS in this specific brand of diet cola 
when consumed prior to a glucose load. Secondly, the study may to an extent 
replicate real-world conditions. For example, the 250 mL beverage amount 
represents an average glass size and NNS are unlikely to be consumed in isolation 
(i.e. it is probable that NNS are consumed in combination with other 
ingredients/nutrients). 
Conclusion 
This unique study adds to the body of research demonstrating the glycaemic 
inactivity of NNS when consumed prior to a glucose load and may have wide-
reaching implications when viewed in the context of current literature. For example, 
findings support the suitability of this particular brand of artificially sweetened diet 
cola for individuals with obesity or those wishing to reduce energy intake and 
achieve weight loss. However, the observation that glycaemia following diet cola 
declined towards the end of the test period reiterates the need for additional robust 
studies in this area. The long-term health effects of NNS consumption remain 
unclear at present. Before any definitive conclusions may be drawn, further research 
is required regarding the efficacy and safety associated with long-term use of non-
nutritive sweeteners as sugar substitutes. 
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